Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 2/20 | 0.78 |
| ▸ | EED | O75530 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CCR3 | P51677 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4892499 | 1.00 | GBA1 (0.78) | GBA1EEDKDM1AMAOBSLC6A2 | |
| SCHEMBL4889591 | 1.00 | GBA1 (0.78) | GBA1EEDKDM1AMAOBSLC6A2 | |
| SCHEMBL31524060 | 0.89 | GBA1 (0.62) | GBA1EEDKDM1AMAOBHRH4 | |
| SCHEMBL1761058 | 0.89 | EED (0.61) | GBA1EEDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3473180 | 0.89 | EED (0.61) | GBA1EEDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8547993 | 0.89 | EED (0.61) | GBA1EEDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9828599 | 0.88 | GBA1 (0.64) | GBA1EEDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL87612 | 0.88 | GBA1 (1.00) | GBA1SLC6A4POLBCCR3 | |
| SCHEMBL9598369 | 0.87 | GBA1 (0.59) | GBA1EEDSLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL3914926 | 0.87 | EED (0.60) | GBA1EEDSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | claimed |
| EP-4561994-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | Genecode (EE) | 2025-06-04 | — | — | EP | claimed |
| CN-120035580-A | Novel piperazinyl sulfonamides and their use as neuroprotective and/or neurorestorative agents | 基因密码公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119948015-A | Novel sulfonamides and their use as neuroprotective and/or nerve repair agents | 基因密码公司 | 2025-05-06 | — | — | CN | claimed |
| WO-2024079351-A1 | NOVEL PIPERAZINE-BASED SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2024-04-18 | — | — | WO | claimed |
| WO-2024023284-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2024-02-01 | — | — | WO | claimed |
| CN-109250403-A | A kind of helix transporting device for bar heat treatment process | 深圳达芬奇创新科技有限公司 | 2019-01-22 | — | — | CN | claimed |
| CN-102227261-A | Hydrogenation of ester, ketone or aldehyde groups with ruthenium complexes having di-amine and phosphorous-nitrogen bidentate ligand | FIRMENICH & CIE | 2011-10-26 | — | — | CN | claimed |
| CN-102164673-A | Hydrogenation of esters or carbonyl groups with phosphino-oxide based ruthenium complexes | FIRMENICH & CIE | 2011-08-24 | — | — | CN | claimed |
| CN-100408643-C | Use of compounds produced by fermentation of marine microorganisms for combating biofouling | HONGKONG SCIENCE AND TECHNOLOG (HK) | 2008-08-06 | — | — | CN | claimed |
| CN-1800273-A | Use of compounds produced by fermentation of marine microorganisms for combating biofouling | HONGKONG SCIENCE AND TECHNOLOG (HK) | 2006-07-12 | — | — | CN | claimed |
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | disclosed |
| EP-4561994-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | Genecode (EE) | 2025-06-04 | — | — | EP | disclosed |
| CN-120035580-A | Novel piperazinyl sulfonamides and their use as neuroprotective and/or neurorestorative agents | 基因密码公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119948015-A | Novel sulfonamides and their use as neuroprotective and/or nerve repair agents | 基因密码公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-0561847-A1 | PHOTOSENSITIVE POLYMERS AND PRINTING PLATES. | LASTRA SPA (IT) | 1993-09-29 | — | — | EP | disclosed |
| WO-1992010523-A1 | PHOTOSENSITIVE POLYMERS AND PRINTING PLATES | LASTRA S.P.A. (IT) | 1992-06-25 | — | — | WO | disclosed |
| US-4487772-A | CARDIOTONIC AGENTS | OTSUKA PHARMACEUTICAL CO. LTD. (JP) | 1984-12-11 | — | — | US | disclosed |
| US-4468402-A | Carbostyril derivatives, process for producing the same and cardiotonic compositions containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-08-28 | — | — | US | disclosed |
| US-4454130-A | CARDIOTONIC, HYPOTENSIVE AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | CNR1, CDR2, SMN1; SMN2 | GBA1 298/4885EED 4019/4885KDM1A 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.